Psoriatic Arthritis Posters and Abstracts from Amsterdam

Annual European Congress of Rheumatology EULAR 2018 meeting in Amsterdam, June 13-16, 2018

Leonard Calabrese, DO, Professor of Medicine at the Cleveland Clinic Lerner College of Medicine and Director, RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic, provides his perspectives on key posters presented at the 2018 European League Against Rheumatism Annual European Congress of Rheumatology, on the treatment of patients with psoriatic arthritis.
Enter your information to begin.

Downloads

Content Areas

  • Efficacy of apremilast
  • Long-term efficacy and safety of ixekizumab
  • Long-term safety of secukinumab
  • Impact of background therapy on tofacitinib efficacy
  • Utility of cardiovascular risk tools

faculty

Leonard Calabrese, DO
Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director, RJ Fasenmyer Center for Clinical Immunology
Cleveland Clinic
Cleveland, Ohio

Cme credit

Available Credit: 1.25 AMA PRA Category 1 Credits™.
Opens: August 10, 2018
Expires: August 09, 2019
Target Audience: Rheumatologists
Dermatologists
Primary Care Physicians
Physician Assistants
Nurse Practitioners
Other Health Care Providers
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.